ARTICLE | Clinical News
Alkermes' Aristada Initio approved for schizophrenia
July 5, 2018 7:25 PM UTC
FDA approved Aristada Initio aripiprazole lauroxil from Alkermes plc (NASDAQ:ALKS) in combination with oral aripiprazole to initiate treatment of schizophrenia in adults. The company expects to launch the product mid-July...
BCIQ Company Profiles